Kezar Life Sciences (KZR) said Monday it will implement a reverse stock split at a ratio of 1-for-10.
The shares will start trading on a post-split basis on Oct. 30, the company said.
The split is part of a plan to regain compliance with Nasdaq's minimum bid price rule of $1 per share, the company said.
Shares of Kezar Life Sciences were down 1.4% in recent trading.
Price: 0.77, Change: -0.01, Percent Change: -1.39
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments